177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment
Crossref DOI link: https://doi.org/10.1007/s00259-016-3481-7
Published Online: 2016-08-10
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yadav, Madhav Prasad
Ballal, Sanjana
Tripathi, Madhavi
Damle, Nishikant Avinash
Sahoo, Ranjit Kumar
Seth, Amlesh
Bal, Chandrasekhar
License valid from 2016-08-10